What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report.

3-Oxy-methyl-D-glucose CEST Cancer DGE MRI Glucose MRI glucoCEST

Journal

Magma (New York, N.Y.)
ISSN: 1352-8661
Titre abrégé: MAGMA
Pays: Germany
ID NLM: 9310752

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 12 07 2021
accepted: 21 12 2021
revised: 20 12 2021
pubmed: 16 1 2022
medline: 11 3 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

Cancer is one of the most devastating diseases that the world is currently facing, accounting for 10 million deaths in 2020 (WHO). In the last two decades, advanced medical imaging has played an ever more important role in the early detection of the disease, as it increases the chances of survival and the potential for full recovery. To date, dynamic glucose-enhanced (DGE) MRI using glucose-based chemical exchange saturation transfer (glucoCEST) has demonstrated the sensitivity to detect both D-glucose and glucose analogs, such as 3-oxy-methyl-D-glucose (3OMG) uptake in tumors. As one of the recent international efforts aiming at pushing the boundaries of translation of the DGE MRI technique into clinical practice, a multidisciplinary team of eight partners came together to form the "glucoCEST Imaging of Neoplastic Tumors (GLINT)" consortium, funded by the Horizon 2020 European Commission. This paper summarizes the progress made to date both by these groups and others in increasing our knowledge of the underlying mechanisms related to this technique as well as translating it into clinical practice.

Identifiants

pubmed: 35032288
doi: 10.1007/s10334-021-00994-1
pii: 10.1007/s10334-021-00994-1
pmc: PMC8901523
doi:

Substances chimiques

Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-104

Subventions

Organisme : horizon 2020 framework programme
ID : Grant Agreement No 667510

Informations de copyright

© 2022. The Author(s).

Références

Quant Imaging Med Surg. 2019 Oct;9(10):1731-1746
pubmed: 31728315
Magn Reson Med. 2019 Nov;82(5):1832-1847
pubmed: 31231853
Magn Reson Med. 2021 Mar;85(3):1335-1349
pubmed: 33031591
J Magn Reson. 2000 Mar;143(1):79-87
pubmed: 10698648
J Cereb Blood Flow Metab. 2013 Aug;33(8):1270-8
pubmed: 23673434
Magn Reson Med. 2018 Mar;79(3):1708-1721
pubmed: 28686796
Radiology. 2017 Dec;285(3):914-922
pubmed: 28628422
Sci Rep. 2015 Aug 20;5:13283
pubmed: 26290434
Sci Rep. 2013 Oct 25;3:3045
pubmed: 24157711
Magn Reson Med. 2019 Mar;81(3):1993-2000
pubmed: 30206994
Nat Med. 2007 Nov;13(11):1382-7
pubmed: 17965722
Magn Reson Med. 2015 Dec;74(6):1556-63
pubmed: 26404120
Quant Imaging Med Surg. 2019 Oct;9(10):1628-1640
pubmed: 31728307
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
J Magn Reson. 2018 Feb;287:1-9
pubmed: 29272735
Eur J Cancer. 1973 Jul;9(7):463-70
pubmed: 4803223
MAGMA. 2022 Feb;35(1):77-85
pubmed: 34890014
Magn Reson Med. 2000 Nov;44(5):799-802
pubmed: 11064415
Nat Med. 2003 Aug;9(8):1085-90
pubmed: 12872167
Front Oncol. 2020 Feb 18;10:161
pubmed: 32133295
NMR Biomed. 2018 Apr;31(4):e3879
pubmed: 29372571
Magn Reson Med. 2014 Nov;72(5):1375-80
pubmed: 25236979
J Nucl Med. 2016 Feb;57 Suppl 1:34S-9S
pubmed: 26834099
Magn Reson Med. 2019 Apr;81(4):2412-2423
pubmed: 30431179
Magn Reson Med. 2017 Feb;77(2):571-580
pubmed: 26857219
Biochim Biophys Acta. 2008 Apr;1778(4):1091-9
pubmed: 18177733
Am J Med. 2002 Aug 1;113(2):146-51
pubmed: 12133753
J Nucl Med. 2019 Mar;60(3):335-341
pubmed: 30413661
Sci Rep. 2017 Feb 07;7:42093
pubmed: 28169369
J Am Chem Soc. 2014 Oct 15;136(41):14333-6
pubmed: 25238643
Magn Reson Med. 2019 Oct;82(4):1471-1479
pubmed: 31106918
Int J Pharm. 2017 Jun 15;525(1):275-281
pubmed: 28433532
J Cereb Blood Flow Metab. 2014 Aug;34(8):1402-10
pubmed: 24865996
Sci Rep. 2016 Jul 27;6:30618
pubmed: 27461165
NMR Biomed. 2021 Dec;34(12):e4602
pubmed: 34423470
Cancer Metastasis Rev. 2019 Jun;38(1-2):25-49
pubmed: 30762162
NMR Biomed. 2021 Feb;34(2):e4431
pubmed: 33103831
Sci Rep. 2016 Sep 07;6:32648
pubmed: 27600054
J Phys Chem B. 2019 Sep 5;123(35):7545-7557
pubmed: 31449408
Magn Reson Med. 2011 May;65(5):1448-60
pubmed: 21500270
Physiol Rev. 2011 Apr;91(2):733-94
pubmed: 21527736
Cancer Res. 2016 Nov 15;76(22):6463-6470
pubmed: 27651313
Magn Reson Med. 2020 Jul;84(1):247-262
pubmed: 31872916
Neuroimage. 2012 Jan 16;59(2):1218-27
pubmed: 21871570
Sci Adv. 2020 May 13;6(20):eaba3884
pubmed: 32426510
Magn Reson Med. 2018 Feb;79(2):1001-1009
pubmed: 29193288
Magn Reson Med. 2018 Aug;80(2):488-495
pubmed: 29569739
Magn Reson Med. 2019 Jan;81(1):275-290
pubmed: 30194742
J Neurosci. 1994 Aug;14(8):5068-76
pubmed: 8046468
Magn Reson Med. 2019 Jan;81(1):573-582
pubmed: 29851141
J Nucl Med. 2001 May;42(5 Suppl):1S-93S
pubmed: 11483694
Nat Med. 2013 Aug;19(8):1067-72
pubmed: 23832090
Magn Reson Med. 2019 Jun;81(6):3798-3807
pubmed: 30793789
J Cereb Blood Flow Metab. 2018 May;38(5):869-880
pubmed: 28485194
Nat Rev Cancer. 2003 Apr;3(4):243-52
pubmed: 12671663
Tomography. 2015 Dec;1(2):105-114
pubmed: 26779568
Magn Reson Med. 2019 Jan;81(1):47-56
pubmed: 30058240
J Cancer Res Ther. 2009 Sep;5 Suppl 1:S21-6
pubmed: 20009289
Magn Reson Med. 2012 Dec;68(6):1764-73
pubmed: 23074027
NMR Biomed. 2019 Sep;32(9):e4113
pubmed: 31313865
Quant Imaging Med Surg. 2019 Oct;9(10):1619-1627
pubmed: 31728306
J Magn Reson. 2019 Jan;298:16-22
pubmed: 30500568
Magn Reson Med. 2018 Feb;79(2):1061-1069
pubmed: 28497566
Mol Imaging Biol. 2022 Feb;24(1):126-134
pubmed: 34383241
Tomography. 2018 Dec;4(4):164-171
pubmed: 30588502
Magn Reson Med. 2021 Aug;86(2):995-1007
pubmed: 33764575
Magn Reson Med. 2003 Dec;50(6):1120-6
pubmed: 14648559
Int J Oncol. 2017 Aug;51(2):498-506
pubmed: 28714513
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683

Auteurs

Mina Kim (M)

Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.

Afroditi Eleftheriou (A)

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.

Luca Ravotto (L)

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.

Bruno Weber (B)

Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Neuroscience Center Zurich, Zurich, Switzerland.

Michal Rivlin (M)

School of Chemistry, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.

Gil Navon (G)

School of Chemistry, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.

Martina Capozza (M)

Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Annasofia Anemone (A)

Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Dario Livio Longo (DL)

Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Torino, Italy.

Silvio Aime (S)

Molecular Imaging Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Moritz Zaiss (M)

Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Neuroradiology, University Clinic Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Kai Herz (K)

Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.

Anagha Deshmane (A)

Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.

Tobias Lindig (T)

Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.

Benjamin Bender (B)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.

Xavier Golay (X)

Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK. x.golay@ucl.ac.uk.

Articles similaires

Humans Ketamine Propofol Pulmonary Atelectasis Female
Humans Magnetic Resonance Imaging Phantoms, Imaging Infant, Newborn Signal-To-Noise Ratio
1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature

Defining multilevel developmental cervical spinal stenosis using MRI.

Prudence W H Cheung, Justin H M Leung, Vivien W Y Lee et al.
1.00
Humans Male Female Magnetic Resonance Imaging Middle Aged

Classifications MeSH